Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis

26Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Leishmaniasis is a neglected protozoan disease affecting over 12 million people globally with no approved vaccines for human use. New World cutaneous leishmaniasis (CL) caused by L. mexicana is characterized by the development of chronic non-healing skin lesions. Using the CRISPR/Cas9 technique, we have generated live attenuated centrin knockout L. mexicana (LmexCen−/−) parasites. Centrin is a cytoskeletal protein important for cellular division in eukaryotes and, in Leishmania, is required only for intracellular amastigote replication. We have investigated the safety and immunogenicity characteristics of LmexCen−/− parasites by evaluating their survival and the cytokine production in bone-marrow-derived macrophages (BMDMs) and dendritic cells (BMDCs) in vitro. Our data shows that LmexCen−/− amastigotes present a growth defect, which results in significantly lower parasitic burdens and increased protective cytokine production in infected BMDMs and BMDCs, compared to the wild type (WT) parasites. We have also determined the safety and efficacy of LmexCen−/− in vivo using experimental murine models of L. mexicana. We demonstrate that LmexCen−/− parasites are safe and do not cause lesions in susceptible mouse models. Immunization with LmexCen−/− is also efficacious against challenge with WT L. mexicana parasites in genetically different BALB/c and C57BL/6 mouse models. Vaccinated mice did not develop cutaneous lesions, displayed protective immunity, and showed significantly lower parasitic burdens at the infection site and draining lymph nodes compared to the control group. Overall, we demonstrate that LmexCen−/− parasites are safe and efficacious against New World cutaneous leishmaniasis in pre-clinical models.

References Powered by Scopus

The Sequence Alignment/Map format and SAMtools

41130Citations
N/AReaders
Get full text

BEDTools: A flexible suite of utilities for comparing genomic features

16321Citations
N/AReaders
Get full text

Of Mice and Not Men: Differences between Mouse and Human Immunology

2877Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates

20Citations
N/AReaders
Get full text

Virulence factors of Leishmania parasite: Their paramount importance in unraveling novel vaccine candidates and therapeutic targets

19Citations
N/AReaders
Get full text

Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis

13Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Volpedo, G., Pacheco-Fernandez, T., Holcomb, E. A., Zhang, W. W., Lypaczewski, P., Cox, B., … Satoskar, A. R. (2022). Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis. Npj Vaccines, 7(1). https://doi.org/10.1038/s41541-022-00449-1

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

47%

Professor / Associate Prof. 7

41%

Lecturer / Post doc 1

6%

Researcher 1

6%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 9

50%

Agricultural and Biological Sciences 4

22%

Immunology and Microbiology 4

22%

Nursing and Health Professions 1

6%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 5
References: 1
Social Media
Shares, Likes & Comments: 105

Save time finding and organizing research with Mendeley

Sign up for free